Limiting smartphone use to treat primary headaches
Official title: Smartphone Use Restriction as Treatment of Primary Headache: a Randomized Controlled Clinical Trial
Run by All India Institute of Medical Sciences · NCT06041997 · Data updated 2026-11-12
This study is testing if cutting back on smartphone use can help people with primary headaches feel better and need less medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | All India Institute of Medical Sciences Academic / other |
| Locations | 1 site (New Delhi, National Capital Territory of Delhi) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | September 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT06041997 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with primary headaches who frequently use smartphones.
✕Probably not a fit
Patients with secondary headaches or those who do not use smartphones may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of smartphone use restriction on patients suffering from primary headaches. It aims to determine whether reducing smartphone usage can lead to decreased medication consumption and improved responsiveness to treatments. Participants will be categorized based on their smartphone usage and randomized into groups receiving either standard treatment or smartphone restriction. The study also seeks to explore the relationship between the type of smartphone use and headache severity, as well as develop an addiction score to identify patients who may benefit from limiting their smartphone use.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological treatment option for patients with primary headaches.
How similar studies have gone: While the specific approach of smartphone restriction is novel, other studies have explored non-pharmacological interventions for headache management with varying degrees of success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Patients ≥18 years of age
2. Diagnosis of primary headache as per the ICHD3Beta classification ("ICHD-3 The International Classification of Headache Disorders 3rd Edition" n.d.)
3. Willing and consenting to participate in the study.
Exclusion Criteria:
* 1\. Secondary headaches 2. Not consenting for participation or follow up
Where it's running
-
Deepti Vibha
New Delhi, National Capital Territory of Delhi, India Recruiting
Study contacts
- Principal investigator: Deepti Vibha — All India Institute of Medical Sciences
- Study coordinator: Deepti Vibha
- Email: deeptivibha@aiims.edu
- Phone: +911126594485
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Scalp block for headache after aneurysmal subarachnoid hemorrhage in ICU patients
We are testing whether a levobupivacaine scalp block added to standard pain medicines can reduce severe headache in adults in the ICU after aneurysmal subarachnoid hemorrhage treated endovascularly.
-
Personality traits, thinking skills, and pain sensitivity in people with headache
This project will see how personality, cognitive function, and central sensitization relate to pain severity, symptom change, and treatment adherence over six months in adults with chronic or episodic headache.
-
New methods to test preventive migraine treatment
This trial will test how the active medicine, placebo injections, and the information given about them affect symptoms in adults with chronic migraine.
-
Aerobic exercise to improve sensory, muscle, and psychosocial symptoms in women with migraine
This trial will test whether supervised aerobic exercise plus one pain neuroscience education session helps women aged 18–48 with migraine reduce disability and improve sensory, musculoskeletal, and psychosocial symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.